Standardized assessment of symptom severity in Schizophrenia and related psychotic disorders.
Evaluating treatment response to antipsychotic medications in clinical trials and specialist practice.
Differentiating between positive (hallucinations/delusions) and negative (apathy/withdrawal) symptom profiles.
Guiding long-term prognosis and rehabilitation planning.
Section 2
Formula & Logic
Scoring Component
The PANSS comprises 30 items across three scales: Positive (7 items), Negative (7 items), and General Psychopathology (16 items). Each item is rated from 1 (absent) to 7 (extreme).
While the Positive Scale often responds quickly to D2 blockade, the Negative Scale is frequently more persistent and is a stronger predictor of long-term functional outcome and disability.
Clinical Pearls
A 20% to 30% reduction in the total PANSS score is generally considered a clinically significant response to antipsychotic treatment.
Distinguish between "Primary" negative symptoms and "Secondary" negative symptoms (caused by depression, EPS, or environmental under-stimulation).
Items like "Lack of Judgment and Insight" (G12) are critical for assessing medication adherence and safety risk.
Section 4
Next Steps
Management Decisions
01
High Positive Score: Consider dose optimization or switching to a more potent antipsychotic (e.g., risperidone, haloperidol).
02
High Negative Score: Focus on psychosocial interventions, vocational rehabilitation, and agents with potentially better negative symptom profiles (e.g., cariprazine, clozapine).
03
Treatment Resistance: If PANSS total remains high despite two 6-week trials of different antipsychotics, Clozapine is indicated.
Section 5
Evidence Appraisal
Primary Reference
The positive and negative syndrome scale (PANSS) for schizophrenia
Kay SR et al. • Schizophrenia Bulletin. 1987;Vol 13, Issue 2. pp. 261-276. The foundational paper establishing the gold standard.
Section 6
Literature
Stanley Kay
Developed by Stanley Kay and colleagues to provide a comprehensive, multidimensional assessment of schizophrenia that moved beyond simple symptom counts.
